Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
United Bankshares
UBSI
$6.62B
| $2.82M | ﹤0.01% |
69,579
+27,434
| +65% | +$1.11M |
|
1977
Emergent Biosolutions
EBS
$248M
| $2.82M | ﹤0.01% |
238,415
+68,225
| +40% | +$1.06M |
|
1978
CALL
Valero Energy
VLO
$85.9B
| $2.8M | ﹤0.01% |
+22,100
| New | +$2.77M |
|
1979
Graphic Packaging
GPK
$3.58B
| $2.8M | ﹤0.01% |
125,985
-242
| -0.2% | -$5.32K |
|
1980
iShares Global Clean Energy ETF
ICLN
$2.4B
| $2.79M | ﹤0.01% |
140,592
-163,179
| -54% | -$3.21M |
|
1981
CNO Financial Group
CNO
$5.11B
| $2.79M | ﹤0.01% |
121,971
+30,504
| +33% | +$658K |
|
1982
Protagonist Therapeutics
PTGX
$9.44B
| $2.78M | ﹤0.01% |
254,887
+38,893
| +18% | +$328K |
|
1983
Cheesecake Factory
CAKE
$5.33B
| $2.78M | ﹤0.01% |
87,660
+24,445
| +39% | +$817K |
|
|
SHAP.WS
1984
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
| $2.77M | ﹤0.01% |
269,273
-15,540
| -5% | -$744 |
|
1985
ATI
ATI
$31.1B
| $2.77M | ﹤0.01% |
92,815
+22,668
| +32% | +$664K |
|
1986
CALL
Huntington Ingalls Industries
HII
$12.8B
| $2.77M | ﹤0.01% |
+12,000
| New | +$2.83M |
|
|
OPI
1987
DELISTED
Office Properties Income Trust
OPI
| $2.77M | ﹤0.01% |
207,233
+21,329
| +11% | +$307K |
|
1988
WillScot Mobile Mini Holdings
WSC
$4.41B
| $2.77M | ﹤0.01% |
61,214
-27,928
| -31% | -$1.25M |
|
|
DCPH
1989
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.76M | ﹤0.01% |
168,339
+12,109
| +8% | +$197K |
|
1990
PUT
Alcon
ALC
$35B
| $2.74M | ﹤0.01% |
40,000
| – | – |
|
1991
HUB Group
HUBG
$2.92B
| $2.74M | ﹤0.01% |
68,888
+5,620
| +9% | +$219K |
|
1992
Valley National Bancorp
VLY
$8.05B
| $2.73M | ﹤0.01% |
241,427
+122,644
| +103% | +$1.44M |
|
1993
Rithm Capital
RITM
$5.69B
| $2.73M | ﹤0.01% |
333,544
-32,748
| -9% | -$273K |
|
1994
Biohaven
BHVN
$2.21B
| $2.72M | ﹤0.01% |
+196,068
| New | +$2.77M |
|
1995
Axcelis
ACLS
$4.31B
| $2.72M | ﹤0.01% |
34,251
-238
| -0.7% | -$16.8K |
|
1996
Western Alliance Bancorporation
WAL
$8.87B
| $2.72M | ﹤0.01% |
45,627
+14,485
| +47% | +$938K |
|
1997
PUT
CRISPR Therapeutics
CRSP
$5.17B
| $2.71M | ﹤0.01% |
+66,600
| New | +$3.53M |
|
1998
Rocket Companies
RKT
$38.8B
| $2.7M | ﹤0.01% |
386,355
+23,298
| +6% | +$170K |
|
1999
Hilton Grand Vacations
HGV
$3.55B
| $2.7M | ﹤0.01% |
70,167
+43,692
| +165% | +$1.73M |
|
|
MDC
2000
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.69M | ﹤0.01% |
85,228
-23,778
| -22% | -$735K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.